These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1060503)
1. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503 [TBL] [Abstract][Full Text] [Related]
2. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy. Uzuka Y; Liong SK; Yamagata S Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159 [TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine. Evans DI; Jones PH; Morley CJ Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498 [TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy for acute myelogenous leukemia in adults (author's transl)]. Ono R Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):740-7. PubMed ID: 4533928 [No Abstract] [Full Text] [Related]
5. L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. Udén AM; Brenning G; Engstedt L; Franzén S; Gahrton G; Gullbring B; Holm G; Höglund S; Jameson S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skårberg KO; Swedberg B; Wadman B; Wide L Scand J Haematol; 1975 Aug; 15(1):72-80. PubMed ID: 1058527 [TBL] [Abstract][Full Text] [Related]
6. [The continuous-DCMP therapy for acute nonlymphocytic leukemia in elderly patients--comparison with younger patients]. Ito T; Yamamoto K; Kinoshita T; Sugiura I; Saito M; Ono Y; Hayashi K; Nagata K; Kamiya O; Ohara K Rinsho Ketsueki; 1989 Apr; 30(4):421-8. PubMed ID: 2769965 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499 [TBL] [Abstract][Full Text] [Related]
8. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia]. Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703 [TBL] [Abstract][Full Text] [Related]
10. Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia. Eppinger-Helft M; Pavlovsky S; Suarez A; Muriel FS; Hidalgo G; Pavlovsky A; Vilaseca G Cancer; 1975 Feb; 35(2):347-53. PubMed ID: 1053936 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia]. Malpas J; Mathé G; Hayat M Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741 [No Abstract] [Full Text] [Related]
13. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report. Paolino W; Resegotti L; Rossi M; Infelise V Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626 [TBL] [Abstract][Full Text] [Related]
14. Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients. Spiers AS; Goldman JM; Catovsky D; Costello C; Buskard NA; Galton DA Cancer; 1977 Jul; 40(1):20-9. PubMed ID: 267503 [TBL] [Abstract][Full Text] [Related]
15. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia. Omura GA Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745 [No Abstract] [Full Text] [Related]
16. Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia. Gluckman E; Basch A; Varet B; Dreyfus B Cancer; 1973 Mar; 31(3):487-91. PubMed ID: 4511906 [No Abstract] [Full Text] [Related]
17. High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group. Lazarus HM; Vogler WR; Burns CP; Winton EF Cancer; 1989 Mar; 63(6):1055-9. PubMed ID: 2917307 [TBL] [Abstract][Full Text] [Related]
18. High remission-induction rate in acute myeloid leukaemia. Gale RP; Cline MJ Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside. Cassileth PA; Katz ME Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749 [TBL] [Abstract][Full Text] [Related]
20. [Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy (author's transl)]. Fülle HH Med Klin; 1977 Apr; 72(15):642-9. PubMed ID: 266111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]